The Relationship Between Lower Urinary Tract Symptoms and Osteoarthritis Symptoms Among Vendors in a Conventional Market
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 송효정 | - |
dc.contributor.author | M. Danet Lapiz Bluhm | - |
dc.contributor.author | Moonju Lee | - |
dc.contributor.author | 김형지 | - |
dc.contributor.author | 문홍상 | - |
dc.date.accessioned | 2022-07-06T08:00:06Z | - |
dc.date.available | 2022-07-06T08:00:06Z | - |
dc.date.created | 2022-04-06 | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 2093-4777 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/139224 | - |
dc.description.abstract | Purpose: This study aimed to investigate lower urinary tract symptoms (LUTS) and the correlation between LUTS and osteo arthritis (OA) symptoms in the vendors working in a conventional market. Methods: This cross-sectional study was conducted on 153 vendors aged 40 and over from August 10th to September 8th, 2020, in a conventional market. Data were collected via the self-reported questionnaires. We assessed LUTS by International Prostate Symptom Score (IPSS) and OA symptoms by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Results: The mean age of 153 subjects was 61.31±9.92 years old. The mean score of IPSS and WOMAC was 5.37±5.68 (range, 0–35) and 16.89±19.61 (range, 0–96). Fifty-one percent of subjects had urinary incontinence at least monthly. Twenty-four point two percent of subjects had moderate-to-severe LUTS which were defined as a score of IPSS ≥8. LUTS were positively correlated with OA symptoms (r=0.41, P<0.001). Conclusions: The results showed that LUTS were associated with OA symptoms, and it also emphasized the need for vendors to be provided with a health education program to manage and prevent their LUTS and OA symptoms. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한배뇨장애요실금학회 | - |
dc.title | The Relationship Between Lower Urinary Tract Symptoms and Osteoarthritis Symptoms Among Vendors in a Conventional Market | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 문홍상 | - |
dc.identifier.doi | 10.5213/inj.2142146.073 | - |
dc.identifier.scopusid | 2-s2.0-85128656902 | - |
dc.identifier.wosid | 000800603700006 | - |
dc.identifier.bibliographicCitation | International Neurourology Journal, v.26, no.1, pp.37 - 44 | - |
dc.relation.isPartOf | International Neurourology Journal | - |
dc.citation.title | International Neurourology Journal | - |
dc.citation.volume | 26 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 37 | - |
dc.citation.endPage | 44 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002828055 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | INCONTINENCE | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | COMMUNITY | - |
dc.subject.keywordPlus | WOMEN | - |
dc.subject.keywordPlus | VALIDATION | - |
dc.subject.keywordPlus | ARTHRITIS | - |
dc.subject.keywordPlus | WOMAC | - |
dc.subject.keywordPlus | HIP | - |
dc.subject.keywordAuthor | Lower urinary tract symptoms | - |
dc.subject.keywordAuthor | Osteoarthritis | - |
dc.subject.keywordAuthor | Occupation | - |
dc.identifier.url | https://www.einj.org/journal/view.php?doi=10.5213/inj.2142146.073 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.